year 16, Issue 6 (November - December 2022)                   Iran J Med Microbiol 2022, 16(6): 551-556 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Shokouh M R, Azhdari F, Pirouzi A, Mohsenzadeh M. Association between the Presence of CMV, BKV and JC Virus and Ovarian Cancer in Fars Province, Southwestern Iran. Iran J Med Microbiol 2022; 16 (6) :551-556
1- Department of Bacteriology and Virology, Shiraz University of Medical Sciences, Shiraz, Iran
2- Cellular and Molecular Gerash Research Center, Gerash University of Medical Sciences, Gerash, Iran
3- Gerash Al-Zahra Fertility Center, Gerash University of Medical Sciences, Gerash, Iran ,
Abstract:   (1157 Views)

Background and Aim: Evidence linking the BK virus (BKV), John Cunningham virus (JCV), and Cytomegalovirus (CMV) to ovarian cancer is inconclusive. Therefore, this study aimed to evaluate the association of BKV, JCV, and CMV in malignant, borderline, benign, and normal ovarian tissues to shed light on the potential role of viral infections in the process of ovarian carcinogenesis.
Materials and Methods: Paraffin-embedded ovarian tissues of 205 patients and 45 normal controls were included in this case-control study conducted from January 2015 to January 2020. The patient group was divided into three subgroups: malignant, borderline, and benign. Amplifying the β-globin gene was conducted to confirm the quality of the DNA extracted. Real-time PCR was used to identify BKV, JCV, and CMV genomes in all specimens.
Results: The mean age of the patients and the control group was 44.0 ± 11.4 and 34.2 ± 12.1 years old, respectively. One, two, and three malignant lesions were positive for the presence of BKV, JCV, and CMV, respectively. These viruses were not detected in any borderline, benign, or control lesions.
Conclusion: The results of this study indicated no association between CMV, BKV, and JCV with ovarian cancer. Therefore, major studies are recommended to confirm these findings.

Full-Text [PDF 491 kb]   (497 Downloads) |   |   Full-Text (HTML)  (561 Views)  
Type of Study: Original Research Article | Subject: Medical Virology
Received: 2022/02/8 | Accepted: 2022/06/26 | ePublished: 2022/09/9

1. Momenimovahed Z, Tiznobaik A, Taheri S, Salehiniya H. Ovarian cancer in the world: epidemiology and risk factors. Int J Women's Health. 2019;11:287. [DOI:10.2147/IJWH.S197604] [PMID] [PMCID]
2. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209-49. [DOI:10.3322/caac.21660] [PMID]
3. Arab M, Noghabaei G. Ovarian cancer incidence in Iran and the world. Radiother Oncol. 2013;1(2):69-72.
4. Králíčková M, Laganà AS, Ghezzi F, Vetvicka V. Endometriosis and risk of ovarian cancer: what do we know? Arch Gynecol Obstet. 2020;301(1):1-10. [DOI:10.1007/s00404-019-05358-8] [PMID]
5. Golrokh Mofrad M, Sadigh ZA, Ainechi S, Faghihloo E. Detection of human papillomavirus genotypes, herpes simplex, varicella zoster and cytomegalovirus in breast cancer patients. J Virol. 2021;18(1):1-10. [DOI:10.1186/s12985-021-01498-z] [PMID] [PMCID]
6. Alinezhad Z, Ghane M, Kaboosi H. Detection and Evaluate the Frequency of Cytomegalovirus and Epstein-Barr Virus in Bladder Tumor Samples in Hamedan Province, 1392. Iran J Med Microbiol. 2015;9(1):22-8.
7. Falahi S, Soleimanjahi H, Kalantar E, Saki A. Evaluation of acute CMV infection prevalence in kidney transplant recipients using PCR and indirect immunofluorescent techniques. Iran J Med Microbiol. 2009;3(2):61-5.
8. Bakhtiyrizadeh S, Hosseini SY, Yaghobi R, Safaei A, Sarvari J. Almost complete lack of human cytomegalovirus and human papillomaviruses genome in benign and malignant breast lesions in Shiraz, Southwest of Iran. Asian Pac J Cancer Prev. 2017;18(12):3319.
9. Tafvizi F, Baghdadi K, Roodbari NH. Lack of relatedness between Human cytomegalovirus in semen and male infertility. Iran J Med Microbiol. 2016;10(3):39-46.
10. Cox M, Kartikasari AER, Gorry PR, Flanagan KL, Plebanski M. Potential impact of human cytomegalovirus infection on immunity to ovarian tumours and cancer progression. Biomedicines. 2021;9(4):351. [DOI:10.3390/biomedicines9040351] [PMID] [PMCID]
11. Jackson SE, Sedikides GX, Okecha G, Poole EL, Sinclair JH, Wills MR. Latent cytomegalovirus (CMV) infection does not detrimentally alter T cell responses in the healthy old, but increased latent CMV carriage is related to expanded CMV-specific T cells. Front Immunol. 2017;8:733. [DOI:10.3389/fimmu.2017.00733] [PMID] [PMCID]
12. Pinto M, Dobson S. BK and JC virus: a review. J Infect. 2014(68):S2-S8. [DOI:10.1016/j.jinf.2013.09.009] [PMID]
13. Assetta B, Atwood WJ. The biology of JC polyomavirus. Biol Chem. 2017;398(8):839-55. [DOI:10.1515/hsz-2016-0345] [PMID]
14. Alibek K, Kakpenova A, Mussabekova A, Sypabekova M, Karatayeva N. Role of viruses in the development of breast cancer. Infect Agents Cancer. 2013;8(1):1-6. [DOI:10.1186/1750-9378-8-32] [PMID] [PMCID]
15. Shokouh MR, Safaei A, Moattari A, Sarvari J. Association of human papilloma virus and Epstein-Barr virus with ovarian cancer in Shiraz, Southwestern Iran. Iran J Pathol. 2020;15(4):292. [DOI:10.30699/ijp.2020.119681.2306] [PMID] [PMCID]
16. Mohammadzadeh A, Baradaran B, Dastmalchi N, Hashemzadeh S, Safaralizadeh R. The correlation between Helicobacter pylori infection and Lnc-OC1 expression in gastric cancer tissues in an Iranian population. J Gastrointest Cancer. 2021;52(2):600-5. [DOI:10.1007/s12029-020-00438-4] [PMID]
17. Farzaneh F, Nadji SA, Khosravi D, Hosseini MS, Bahremani MH, Chehrazi M, et al. Lack of HPV in benign and malignant epithelial ovarian tumors in Iran. Asian Pac J Cancer Prev: APJCP. 2017;18(5):1233.
18. Dadashi M, Eslami G, Faghihloo E, Pourmohammad A, Hosseini J, Taheripanah R, et al. Detection of human papilloma virus type 16 in epithelial ovarian tumors samples. Arch Clin Infect Dis. 2017;12(1). [DOI:10.5812/archcid.39666]
19. Radley D, Saah A, Stanley M. Persistent infection with human papillomavirus 16 or 18 is strongly linked with high-grade cervical disease. Hum Vaccines Immunother. 2016;12(3):768-72. [DOI:10.1080/21645515.2015.1088616] [PMID] [PMCID]
20. Mokhtari F, Ghane M. Diagnosis and Prevalence of Cytomegalovirus in Stroke Patients with PCR and Compared Results With the Control Group. Iran J Med Microbiol. 2019;13(2):151-2. [DOI:10.30699/ijmm.13.2.151]
21. Yuan R, Zhang C, Li Q, Ji M, He N. The impact of marital status on stage at diagnosis and survival of female patients with breast and gynecologic cancers: A meta-analysis. Gynecol Oncol. 2021;162(3):778-87. [DOI:10.1016/j.ygyno.2021.06.008] [PMID]
22. Andrews L, Mutch DG. Hereditary ovarian cancer and risk reduction. Best Pract Res Clin Obstet Gynaecol. 2017;41:31-48. [DOI:10.1016/j.bpobgyn.2016.10.017] [PMID]
23. Kaneyasu T, Mori S, Yamauchi H, Ohsumi S, Ohno S, Aoki D, et al. Prevalence of disease-causing genes in Japanese patients with BRCA1/2-wildtype hereditary breast and ovarian cancer syndrome. NPJ Breast Cancer. 2020;6(1):1-13. [DOI:10.1038/s41523-020-0163-1] [PMID] [PMCID]
24. Yang Z, Jin P, Xu S, Zhang T, Yang X, Li X, et al. Corrigendum to "Dicer reprograms stromal fibroblasts to a pro-inflammatory and tumor-promoting phenotype in ovarian cancer" [Cancer Lett 415 (20-29)]. Cancer Lett. 2018;436:159-60. [DOI:10.1016/j.canlet.2018.07.038] [PMID]
25. Yang Z, Jin P, Xu S, Zhang T, Yang X, Li X, et al. Dicer reprograms stromal fibroblasts to a pro-inflammatory and tumor-promoting phenotype in ovarian cancer. Cancer Lett. 2018;415:20-9. [DOI:10.1016/j.canlet.2017.11.026] [PMID]
26. Idahl A, Lundin E, Elgh F, Jurstrand M, Møller JK, Marklund I, et al. Chlamydia trachomatis, Mycoplasma genitalium, Neisseria gonorrhoeae, human papillomavirus, and polyomavirus are not detectable in human tissue with epithelial ovarian cancer, borderline tumor, or benign conditions. Am J Obstet Gynecol. 2010;202(1):71.e1-.e6. [DOI:10.1016/j.ajog.2009.07.042] [PMID]
27. Ingerslev K, Høgdall E, Skovrider-Ruminski W, Schnack TH, Lidang M, Høgdall C, et al. The prevalence of EBV and CMV DNA in epithelial ovarian cancer. Infect Agents Cancer. 2019;14(1):1-6. [DOI:10.1186/s13027-019-0223-z] [PMID] [PMCID]
28. Paradowska E, Jabłońska A, Studzińska M, Wilczyński M, Wilczyński JR. Detection and genotyping of CMV and HPV in tumors and fallopian tubes from epithelial ovarian cancer patients. Scientific reports. 2019;9(1):1-10. [DOI:10.1038/s41598-019-56448-1] [PMID] [PMCID]
29. Shanmughapriya S, Senthilkumar G, Vinodhini K, Das BC, Vasanthi N, Natarajaseenivasan K. Viral and bacterial aetiologies of epithelial ovarian cancer. Eur J Clin Microbiol Infect Dis. 2012;31(9):2311-7. [DOI:10.1007/s10096-012-1570-5] [PMID]
30. Rådestad AF, Estekizadeh A, Cui HL, Kostopoulou ON, Davoudi B, Hirschberg AL, et al. Impact of human cytomegalovirus infection and its immune response on survival of patients with ovarian cancer. Transl Oncol. 2018;11(6):1292-300. [DOI:10.1016/j.tranon.2018.08.003] [PMID] [PMCID]

Add your comments about this article : Your username or Email:

Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Iranian Journal of Medical Microbiology

Designed & Developed by : Yektaweb | Publisher: Farname Inc